dc.contributor.author
Driller, Ronja
dc.date.accessioned
2019-02-18T10:03:13Z
dc.date.available
2019-02-18T10:03:13Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/23914
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-1689
dc.description.abstract
Enzymes play an indispensable role in our everyday life. They are not only catalysing
a vast number of reactions in our body, they are incorporated into many industrial
processes. In the light of pollution and decline of fossil resources it is essential to
develop new production routes to pharmaceutical and chemical target compounds. The
exaggerated use of antibiotics and the resulting increase of multi‐resistant bacteria is
another threat of our century. Solving this problem requires deep understanding of
antibiotic resistance mechanisms to enable rational drug‐design.
The main focus of the thesis lies on terpene synthases, which catalyse the
cyclisation of linear isoprenoid precursors to complex macrocycles. These compounds
are high commercial targets of the chemical and pharmaceutical industry. Terpenes
constitute the largest group of natural compounds. Especially in the class of the
diterpenes many compounds possess antibacterial, anti‐viral, insecticidal and antiinflammatory properties. White biotechnology opens up new routes for the production
of terpenes in bacteria in a sustainable manner. In order to optimise terpene titers in
bacteria, structural knowledge of the involved terpene synthases is crucial. Here, we
report the crystal structures of the diterpene synthases CotB2 and IES in complex with
various substrate‐analogues. Furthermore, the structure of the oleate hydratase OhyRe
was elucidated. Products of this enzyme are used as surfactants and lubricants in
industry.
The X‐ray crystal structures of biotechnologically relevant enzymes obtained during
this thesis contribute to illustrate their reaction mechanisms and binding modes.
As another part of this thesis, the structure of AlbAS, a bacterial antibiotic‐binding
protein, was solved. The protein structure sheds light on the binding mechanism of the
antibacterial drug albicidin at a molecular level.
en
dc.format.extent
44, 7, 5, 17, 11, 13, 8, 34 Seiten
dc.rights.uri
http://www.fu-berlin.de/sites/refubium/rechtliches/Nutzungsbedingungen
dc.subject
protein crystallography
en
dc.subject
biotechnology
en
dc.subject.ddc
500 Naturwissenschaften und Mathematik::570 Biowissenschaften; Biologie::572 Biochemie
dc.title
Structural studies of biotechnologically relevant enzymes
dc.contributor.gender
female
dc.contributor.firstReferee
Wahl, Markus
dc.contributor.furtherReferee
Brück, Thomas
dc.date.accepted
2018-12-03
dc.identifier.urn
urn:nbn:de:kobv:188-refubium-23914-6
refubium.affiliation
Biologie, Chemie, Pharmazie
dcterms.accessRights.dnb
free
dcterms.accessRights.openaire
open access